Trials / Conditions / ICANS
ICANS
3 registered clinical trials studyying ICANS — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Neurological and Cognitive Dysfunction Following CAR-T Treatment. ICANS and Beyond NCT07375628 | Karolinska University Hospital | — |
| Recruiting | Adjunctive Methylene Blue for Immunotherapy-related CRS and ICANS: Phase I Study NCT07169487 | Institute of Hematology & Blood Diseases Hospital, China | Phase 1 |
| Active Not Recruiting | Study to Evaluate the Role of Siltuximab in Treatment of Cytokine Release Syndrome (CRS) and Immune Effector C NCT04975555 | University of Alabama at Birmingham | Phase 2 |